KUALA LUMPUR (June 16): Eye-care specialist ISEC Healthcare Ltd said two of its ambulatory surgical centres in Malaysia will administer Covid-19 vaccination services to the Malaysian public under an agreement with Ministry of Health (MoH)-backed ProtectHealth Corp Sdn Bhd.

In a filing with the Singapore bourse yesterday, ISEC said its Malaysian ambulatory surgical centres — ISEC Sdn Bhd in Kuala Lumpur and Southern Specialist Eye Centre Sdn Bhd in Melaka (collectively ISEC Malaysia) — are participating as Malaysia’s private Covid-19 vaccination centres to administer vaccination services to the Malaysian public.

"This is an initiative by ISEC Malaysia to contribute to the community in fighting the Covid-19 pandemic. ISEC Malaysia will begin its vaccination services soon after the completion of all necessary training and preparations, and the programme is expected to end in February 2022. 

"The vaccination services may be extended if necessary, and early termination is allowed with mutual agreement. For each of our ISEC Malaysia centres, we intend to start the vaccination services with a minimum of 50 vaccinations per day per centre (five days a week), and we plan to increase the number once our staff are familiar with, and are efficient in, the processes and workflow.

"The vaccine costs are to be borne by the MoH, and vaccination is given free of charge to eligible members of the public. ISEC Malaysia will receive RM14 per dose of vaccination injection, which serves to help partially defray any manpower and other incidental costs incurred by the centres in administering the vaccination services,” ISEC said.

According to ISEC, ProtectHealth Corp, as a not-for-profit company, administers and manages initiatives related to financing healthcare services as mandated by the MoH. 

Get the latest news @ www.EdgeProp.my

Subscribe to our Telegram channel for the latest stories and updates 

Click here for more property stories

  1. Sinovac vaccine efficacy drops to 28% in three to five months — report
  2. Solution Group obtains MoH approval for private sales of CanSino vaccine
  3. MoH: Sinovac, AstraZeneca vaccines get conditional approval for use as booster shots